News Release

China Patent and Trademark Office Grants Patent for F351,GNI’s Key Therapeutic Product for Liver Disease

• GNI Announces IND Approval in China for Novel Liver Disease Drug F351
• China Patent and Trademark Office Grants Patent for F351, GNI’s Key Therapeutic Product for Liver Disease